News

Lisata Therapeutics Shares Financial Results and Key Updates

Lisata Therapeutics Shares Financial Results and Key Updates

Lisata Therapeutics Financial Reporting and Updates

LISATA THERAPEUTICS, INC., a prominent clinical-stage pharmaceutical company, is gearing up to share its financial results for the fiscal year ending December 31, 2024. Scheduled for Thursday, February 27, 2025, this announcement will occur after the market closes. The company is known for its innovative therapies aimed at treating advanced solid tumors and other serious diseases.

Participation in the Conference Call

Investors and stakeholders interested in the outcome are encouraged to participate in the conference call that will follow the announcement at 4:30 p.m. Eastern time. To ensure you can join without hassle, it's advisable to register for the call early. Participants will receive an email containing all necessary dial-in information. To ensure a smooth experience, joining the call at least 15 minutes beforehand is recommended.

About Lisata Therapeutics

Lisata Therapeutics stands at the forefront of pharmaceutical innovation, focusing on the discovery, development, and commercialization of advanced therapies for various diseases, particularly advanced solid tumors. Their cyclic peptide product candidate, certepetide, represents a significant advancement in treatment, as it’s designed to enhance drug delivery directly to solid tumors through a novel uptake pathway. This innovative method increases the efficacy of co-administered or tethered anti-cancer drugs.

Strategic Partnerships and Future Goals

The company has already forged remarkable commercial and research partnerships based on its CendR Platform technology. Looking ahead, Lisata Therapeutics anticipates announcing a series of milestones in the upcoming 1.5 years that will enhance their research and operational capabilities. The projected budget is expected to support the company's operations through the second quarter of 2026 as they prepare for key data releases from ongoing and future clinical trials.

Innovative Mechanisms of Action

One of the key highlights of Lisata's product pipeline is the mechanism of action of certepetide. This investigational drug is not only a testament to their commitment to innovation but also provides a pathway for more targeted and effective treatments. The company believes that understanding this mechanism can significantly bolster their position in the market and enhance patient outcomes.

Company Contact Information

For investors seeking more information, Lisata Therapeutics encourages direct contact through:

Investors:
Lisata Therapeutics
John Menditto
Vice President, Investor Relations and Corporate Communications
Phone: 908-842-0084
Email: jmenditto@lisata.com

For media inquiries:
ICR Healthcare
Elizabeth Coleman
Account Supervisor
Phone: 203-682-4783
Email: elizabeth.coleman@icrhealthcare.com

Frequently Asked Questions

What are the key focuses of Lisata Therapeutics?

Lisata Therapeutics focuses on developing innovative therapies for advanced solid tumors and other serious diseases, emphasizing precision medicine.

When will Lisata report its financial results?

Lisata Therapeutics plans to report its financial results for the year ending December 31, 2024, on February 27, 2025.

How can investors participate in the conference call?

Investors can register for the conference call through the link provided by Lisata prior to the announcement.

What is certepetide's role in Lisata's product pipeline?

Certepetide is an investigational drug designed to improve the delivery of anti-cancer therapies specifically to solid tumors through a novel uptake mechanism.

Who can I contact for more information on Lisata?

Investors can contact John Menditto via email or phone, while media inquiries can be directed to Elizabeth Coleman.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Aosom Unveils Its Boldest Black Friday Extravaganza

Updated Category News Views 67

Black Friday Heat Kicks Off Early at Aosom All the seasoned shoppers out there smell a deal from a mile away, and Aosom isn't taking any chances by launching their Black Friday bash smack dab on November 2nd. This isn’t just any sale, it’s shaping up to be their most gigantic festival of discounts yet. Across Europe and North America, folks are rubbing their hands...

Continue Reading
Stellantis Harnesses AI for Customer Connection Boost

Updated Category News Views 114

Trading Mayhem: Pre-Market Vibes Ever put your ear to the ground on the NYSE floor and felt that buzz of untamed optimism clashing with skepticism? Today it's all about connections, from the data-driven to the familial. Imagine Stellantis (NYSE: STLA) is making a play, aligning with Amperity in an ambitious attempt to make customer interactions feel more personal. Now,...

Continue Reading
Boosting Heating Efficiency in Aging Massillon Homes

Updated Category News Views 58

Tackling the Age-Old Heating Puzzle Ah, the charm of an older home—from the creaky floors to the vintage architecture, it's something else. But, let's face it, keeping these houses warm can feel like patching up an old ship. Our man Reid Sittler, HVAC aficionado from Massillon, Ohio, shares some no-nonsense insights on how to stop your precious heat from slipping...

Continue Reading
Comedy Giants Unite for 'We Them One's' Tour 2027

Updated Category News Views 80

Comedy's Heavyweights Hit the Road for 2027 Tour Kicking off in Milwaukee on February 5, 2027, comedy gets a new spotlight as BMN Entertainment launches the much-anticipated return of the 'We Them One's' Comedy Tour. This isn't your run-of-the-mill comedy gig, folks. We're talking about headlining act Mike Epps, comedy’s sharp shooter and stage powerhouse, teaming up...

Continue Reading
Monetary Metals' Bold $38M Gold Bond: A Strategic Leap

Updated Category News Views 129

A Golden Opportunity in Uncertain Times Monetary Metals just pulled a rabbit outta the hat with this $38 million gold bond. That’s tripling the size from their 2024 offering. Normally, I'm skeptical about flashy bond numbers, but there's a glint of genius here. In a world teetering on the brink of financial chaos, investors are itching for something solid. And gold?...

Continue Reading
Vantage's Pre-IPO CFD: New Frontier or Gamble?

Updated Category News Views 123

Ah, the thrill of the pre-IPO buzz. Vantage has thrown its hat into the ring with a pre-IPO CFD offering, giving stock jockeys like you and me a chance to express our bullish or bearish convictions before a company goes public. The question is: does this open new doors for the sharp-eyed investor, or are we just adding another layer of risk onto an already wild ride?...

Continue Reading
November Oil Outlook: OPEC+ Steady, Key Earnings Ahead

Updated Category News Views 79

Oil's November Gambit: OPEC+ and U.S. Dynamics November's here, and boy, it's shaping up to be a wild one for the oil market. OPEC+ decided to stick with their oil production targets for December, leaving the supply faucets unchanged. This group, including big players like Saudi Arabia and Russia, met virtually and chose to hit the brakes on any changes just yet. With the...

Continue Reading
Tampa Welcomes Global Art Fair October 2026

Updated Category News Views 73

Tampa Steps into the Global Art Scene Get this, Tampa is gearing up for its slice of the global art pie. Come October 2026, the Tampa Convention Center will transform into a bustling hub of creativity and culture. With over 300 artists slated to pour in from every corner of the globe, this isn't just any old art fair—it's Art Fair Tampa, and it's promising to be a...

Continue Reading
Industrial Automation Booms: Market to Hit $410B by 2031

Updated Category News Views 126

Industrial Automation Surge: A New Era Dawns There's no denying it, folks: the gears are turning at a breakneck pace in the industrial automation world. We've got our eyes set on a staggering climb from $266.7 billion in 2026 to a jaw-dropping $410.3 billion by 2031. That's a 9% annual growth rate that's got investors salivating. Robotics and AI: Leading the Charge Look...

Continue Reading
Discover Myrtle Beach's Festive Charm This Season

Updated Category News Views 39

Uniquely Coastal Celebrations in Myrtle Beach Forget the snow, friends. Picture this: you’re swapping out cozy firesides for ocean breezes this holiday season. Down in Myrtle Beach, the holidays have a bit of a coastal twist. From the vibrant Boardwalk along the oceanfront to the historic charm of riverside Conway, this area is lighting up its 14 different communities...

Continue Reading

Top 5 Most Recently Viewed Articles

Marsh McLennan Approves Increased Quarterly Dividend Payout

Updated Category News Views 69

Marsh McLennan Announces Quarterly Cash Dividend Marsh McLennan (NYSE: MMC) has announced its latest quarterly cash dividend, set at $0.815 per share for its outstanding common stock. This dividend highlights the company's solid financial health and will be payable to all stockholders on record as of a designated upcoming date. As a leading global professional services...

Continue Reading
A2P and P2A Messaging Market Growth Forecast Shifts Focus

Updated Category News Views 51

A2P and P2A Messaging Market Growth Forecast The A2P and P2A messaging market is witnessing tremendous growth owing to the escalation of mobile device usage and the increasing demand for effective communication between businesses and their clientele. As organizations strive to boost customer engagement and streamline their operations, the adoption of automated messaging...

Continue Reading
Rapid7 Unveils Vector Command Advanced to Enhance Security Testing

Updated Category News Views 199

Rapid7 Launches Vector Command Advanced In today's cyber landscape, organizations are increasingly under pressure to demonstrate the effectiveness of their security measures. To address this need, Rapid7, Inc. (NASDAQ: RPD), a pioneering force in threat detection and exposure management, has introduced Vector Command Advanced. This innovative offering enhances their...

Continue Reading
Investigation Launched Against Fortrea Holdings Inc. (FTRE)

Updated Category News Views 309

Fortrea Holdings Inc. Faces Investigation The law firm of Kirby McInerney LLP has initiated an investigation into Fortrea Holdings Inc. (NASDAQ: FTRE) on behalf of concerned investors. This inquiry aims to determine if the company and its executives have violated federal securities laws or engaged in questionable business practices that may have adversely impacted...

Continue Reading
Regular Dividend Announcement for TDb Split Corp's Equity Shares

Updated Category News Views 241

TDb Split Corp. Announces Monthly Dividend for Shareholders In a recent announcement, TDb Split Corp. has confirmed its monthly distribution for shareholders. For each Class A share, the dividend is set at $0.05000, which translates to an annualized figure of $0.60. Meanwhile, holders of Priority Equity shares will receive $0.05833, or $0.700 on an annual basis. These...

Continue Reading